Trial intelligence / Profile preview

Metformin in Obese Non-diabetic Pregnant Women

NCT01273584Phase 3Completed

Sponsor
Epsom and St Helier University Hospitals NHS Trust
Start
Oct 2010
Primary completion
Jul 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of liquid metformin (Aspargo Labs) in obesity (2 arms), sponsored by Epsom and St Helier University Hospitals NHS Trust. Primary endpoint: Birth Weight centile (z-score). Started Oct 2010; status: completed.

02

Drugs

liquid metformin (Aspargo Labs)
03

Conditions

obesity

Beyond the preview

Go deeper on NCT01273584.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01273584.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call